通过理性组合策略克服B-ALL对向和免疫疗法的耐药性
Miguel Quijada-Álamo1,2,3,4,5, Grace Freed1,2,3,4,5, Elvin Wagenblast1,2,3,4,5,6
1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Blood cancer discovery
|April 27, 2025
概括
向疗法和免疫疗法对B细胞急性淋巴细胞白血病 (B-ALL) 有希望. 整合这些治疗方法可以克服复发或耐药B-ALL患者的耐药性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- B细胞急性淋巴细胞白血病 (B-ALL) 在向疗法和免疫疗法方面取得了进展.
- 复发性和耐药性B-ALL仍然是重要的临床挑战,尽管目前的治疗方法.
研究的目的:
- 审查将向药物与B-ALL免疫疗法结合在一起的潜力.
- 探索克服B-ALL.治疗耐药性的策略.
主要方法:
- 在B-ALL.中针对性治疗和免疫治疗的文献综述.
- 对抗性机制和潜在组合策略的分析.
主要成果:
- 组合疗法可以提供对B-ALL细胞的协同效应.
- 克服抗性对于改善复发性/耐药性B-ALL的结果至关重要.
结论:
- 整合向药物和免疫疗法是针对B-ALL的一种有希望的策略.
- 这种方法可以提高患者的长期生存率和治疗疗效.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:40Cell-mediated Immune Responses
65.2K
Overview
65.2K
01:24B Cell Activation and Differentiation
1.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.2K